Science Explorer Back to mapMap
Discussion
Researcher · AULSS 2 Marca Trevigiana · Italy

Elisa Vian

Elisa Vian publishes mostly in Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine, on topics such as Respiratory viral infections research, SARS-CoV-2 and COVID-19 Research and SARS-CoV-2 detection and testing.

ORCID 0000-0002-4315-6342 OpenAlex
World rank
#2,179,191
of 7,710,434 ranked researchers
Rank in Italy
#72,494
of 242,206
Works
23
Citations
457
Citations per work
19.9
h-index
8
i10-index 8Top 70% in Epidemiology
Elisa Vian

What does Elisa Vian research?

Elisa Vian's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (4%).

Health Sciences: 14 works · 62.3% of their workMedicine: 14 works · 62.3% of their workEpidemiology: 6 works · 26.1% of their workInfectious Diseases: 5 works · 20.3% of their workCardiology and Cardiovascular Medicine: 1 works · 5.8% of their workPulmonary and Respiratory Medicine: 1 works · 5.8% of their workSurgery: 1 works · 4.3% of their workEverything else: 8 works · 33.4% of their workLife Sciences: 1 works · 4.3% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 4.3% of their workGenetics: 1 works · 4.3% of their workTHEIR WORKElisa Vian23works
Life Sciences4%Health Sciences62%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1462.3%
  2. Everything else833.4%
    1. Biochemistry, Genetics and Molecular Biology14.3%
  1. 1Epidemiology26% of their works
  2. 2Infectious Diseases20% of their works
  3. 3Pulmonary and Respiratory Medicine6% of their works
  4. 4Cardiology and Cardiovascular Medicine6% of their works
  5. 5Surgery4% of their works
  6. 6Genetics4% of their works

Research topics

Which keywords describe Elisa Vian's research?

The keywords of their largest research topics: Epidemiology, SARS-CoV-2, Human Metapneumovirus, Respiratory Syncytial Virus, ACE2 Receptor, Pandemic, Biosensors and Coronavirus.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Epidemiology163 topics
  2. SARS-CoV-2113 topics
  3. Human Metapneumovirus101 topic
  4. Respiratory Syncytial Virus101 topic
  5. ACE2 Receptor72 topics
  6. Pandemic72 topics
  7. Biosensors62 topics
  8. COVID-1941 topic
  9. Coronavirus41 topic
  10. Diagnostics41 topic
  11. Vaccine41 topic
  12. Clinical Characteristics31 topic
  13. Community-Acquired Pneumonia31 topic
  14. Gene Therapy31 topic
  15. Pneumococcal Conjugate Vaccine31 topic
  16. Thrombosis31 topic
  17. Viral Vectors31 topic
  18. Epitope Prediction21 topic
  19. Loop-Mediated Isothermal Amplification21 topic
  20. Paper-Based Microfluidics21 topic
  21. Peptide-MHC Binding21 topic

Where does Elisa Vian work?

Elisa Vian's main affiliation in the publication record is AULSS 2 Marca Trevigiana, Italy.

How many publications and citations does Elisa Vian have?

OpenAlex counts 23 works and 457 citations for Elisa Vian, an h-index of 8, ranking #2,179,191 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Elisa Vian. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.